Company Profile

Previously dba Eclipse Enterogenesis Inc - renamed Eclipse Regenesisis - personnel organize around working on development of a therapeutic device intended to improve tissue regeneration therapy. The First Tissue Regeneration Therapy For Short Bowel Syndrome (SBS), the company's developed device is designed to specialize in production of a restorative therapy that stimulate the growth of new intestine tissues thereby treating Short Bowel Syndrome, enabling patients to address their nutrition malabsorption disorder caused by a lack of enough functional small intestine. The firm's commitment to patient-centered innovation is driven by their partnerships with some of the leading healthcare organizations in the world: Boston Children’s Hospital, Cincinnati Children’s, UCLA Health, and Stanford Medicine.